Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Jansen

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Biochemical Pharmacology|August 30, 2022
A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancerL Wester, S Venneker, M Hazenoot, et al.
Breast Cancer Research and Treatment|July 17, 2008
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancerMaurice P H M Jansen, Kirsten Ruigrok-Ritstier, Lambert C J Dorssers, et al.
Cell Death and Differentiation|February 16, 2024
Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancerTong Xu, Mathijs P Verhagen, Miriam Teeuwssen, et al.
The American Journal of Gastroenterology|October 26, 2020
Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic CancerIris J M Levink, Kateryna Nesteruk, Dido I Visser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profilingMaurice P H M Jansen, John A Foekens, Iris L van Staveren, et al.
Breast Cancer Research and Treatment|April 18, 2013
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifenDiana E Ramirez-Ardila, Jean C Helmijr, Maxime P Look, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing DataJob van Riet, Niels M G Krol, Peggy N Atmodimedjo, et al.
Scientific Reports|June 27, 2023
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panelsElisabeth M Jongbloed, Maurice P H M Jansen, Vanja de Weerd, et al.
International Journal of Cancer|November 16, 2005
Molecular profiling of platinum resistant ovarian cancerJozien Helleman, Maurice P H M Jansen, Paul N Span, et al.
Biomolecules|March 12, 2020
<i>TP53</i> Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian CancerSilvia R Vitale, Floris H Groenendijk, Ronald van Marion, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Biochemical Pharmacology|August 30, 2022
A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancerL Wester, S Venneker, M Hazenoot, et al.
Breast Cancer Research and Treatment|July 17, 2008
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancerMaurice P H M Jansen, Kirsten Ruigrok-Ritstier, Lambert C J Dorssers, et al.
Cell Death and Differentiation|February 16, 2024
Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancerTong Xu, Mathijs P Verhagen, Miriam Teeuwssen, et al.
The American Journal of Gastroenterology|October 26, 2020
Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic CancerIris J M Levink, Kateryna Nesteruk, Dido I Visser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profilingMaurice P H M Jansen, John A Foekens, Iris L van Staveren, et al.
Breast Cancer Research and Treatment|April 18, 2013
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifenDiana E Ramirez-Ardila, Jean C Helmijr, Maxime P Look, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing DataJob van Riet, Niels M G Krol, Peggy N Atmodimedjo, et al.
Scientific Reports|June 27, 2023
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panelsElisabeth M Jongbloed, Maurice P H M Jansen, Vanja de Weerd, et al.
International Journal of Cancer|November 16, 2005
Molecular profiling of platinum resistant ovarian cancerJozien Helleman, Maurice P H M Jansen, Paul N Span, et al.
Biomolecules|March 12, 2020
<i>TP53</i> Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian CancerSilvia R Vitale, Floris H Groenendijk, Ronald van Marion, et al.
Pageof 26